Uncontrolled diabetes mellitus: A risk factor for post COVID fibrosis

Abstract

Dear Editor,

The Corona virus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in the Wuhan province of china in December 2019. COVID-19 spread to the world in a short time and was declared as public health emergency of international concern by World Health Organization...

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

References

George PM, Wells AU, Jenkins RG. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. Lancet Respir Med 2020;8:807-15.

Hussain A, Bhowmik B, do Vale Moreira NC. COVID-19 and diabetes: Knowledge in progress. Diabetes Res Clin Pract 2020;162:108142.

Fraser E. Long term respiratory complications of Covid-19. BMJ 2020;370:m3001.

Vasarmidi E, Tsitoura E, Spandidos DA, et al. Pulmonary fibrosis in the aftermath of the COVID-19 era (Review). Exp Ther Med 2020;20:2557-60.

Ojo AS, Balogun SA, Williams OT, Ojo OS. Pulmonary fibrosis in COVID-19 survivors: Predictive factors and risk reduction strategies. Pulm Med 2020;2020:1-10.

Published
2021-01-25
Info
Issue
Section
COVID-19 - Collection of articles on the Coronavirus outbreak
Keywords:
Pulmonary fibrosis, risk factors, infection
Statistics
  • Abstract views: 313

  • PDF: 182
How to Cite
Mrigpuri, P., Sonal, S., Spalgais, S., Goel, N., Menon, B., & Kumar, R. (2021). Uncontrolled diabetes mellitus: A risk factor for post COVID fibrosis. Monaldi Archives for Chest Disease, 91(1). https://doi.org/10.4081/monaldi.2021.1607